Home/Filings/4/0000899243-21-034986
4//SEC Filing

Krehlik Carrie 4

Accession 0000899243-21-034986

CIK 0001629137other

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 8:00 PM ET

Size

11.0 KB

Accession

0000899243-21-034986

Insider Transaction Report

Form 4
Period: 2021-09-01
Krehlik Carrie
Chief Human Resources Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-09-01+49,60049,600 total
    Exercise: $29.85Exp: 2031-08-31Common Stock (49,600 underlying)
  • Award

    Restricted Stock Units

    2021-09-01+32,24032,240 total
    Common Stock (32,240 underlying)
  • Award

    Restricted Stock Units

    2021-09-01+42,40042,400 total
    Common Stock (42,400 underlying)
Footnotes (4)
  • [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
  • [F2]The RSUs vest with respect to 25% of the underlying shares on September 1, 2022 and in six semi-annual installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
  • [F3]The RSUs vest in installments conditioned upon the achievement, on or before June 30, 2024, of up to three specified market price thresholds of the Issuer, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
  • [F4]The stock option vests with respect to 25% of the underlying shares on August 2, 2022 and in 12 equal quarterly installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Issuer

Global Blood Therapeutics, Inc.

CIK 0001629137

Entity typeother

Related Parties

1
  • filerCIK 0001823899

Filing Metadata

Form type
4
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 8:00 PM ET
Size
11.0 KB